U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5871518

Smoking Cessation Lighter and Method

A lighter for tobacco products suppresses the urge to smoke by operant conditioning.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 548/324.1 - The chalcogen, X, is in a -C(=X)- group


Subclass of Class 548 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the chalcogen, X (i.e., oxygen, sulfur,
No. of patents: 228
Last issue date: 10/21/2008


1            
NumberTitleIssue Date
7439242PPARγ modulators
Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity. ...
10/21/2008
7378530Anti-cancer and anti-microbial 5-membered heterocyclic compounds
Disclosed herein are various novel oxazolidinone, imidazolidinone, and thiazolidinone analogs and methods of treating cancer and/or microbial infection using these analogs. Particular 4-oxazolidinone compounds are shown to have anti-cancer and anti-microbial activit...
05/27/2008
73097913-phenylpropionic acid derivatives
The invention relates to new compounds, being 3-phenylpropionic acid derivatives of formula I wherein W represents COOH group or its bioisosters, or —COO—C1–C4-alkyl group; Y represents NH, N—C1–C10-alkyl, O, or ...
12/18/2007
7279582Retroviral protease inhibiting compounds
A compound of the formula: is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed. ...
10/09/2007
7109202Aminothaizoles and their use as adenosine receptor antagonists
Compounds of formula (I) in free or salt form, where A is a C6-C15 monovalent aromatic group. R1 is hydrogen, phenyl optionally substituted by one or more substituents selected from halogen, cyano, hydroxy, C1–C8
09/19/2006
7087763Process for preparation of alkylimidazolidone (meth)acrylates
The invention relates to a process for the preparation of alkylimidazolidone (meth)acrylates, generally expressed as compound (I): that are prepared by reacting at least one (meth)acrylate of formula (II):
08/08/2006
7074937Method for production of additives for lubricating oils
A method for making a compound of formula (I) wherein bonds a and b are single or double bonds, provided that one of a and b is a single bond and the other is a double bond; one of B1 and B2
07/11/2006
7071223Benzamide inhibitors of the P2Xreceptor
The present invention provides benzamide inhibitors of the P2X7 receptor of the formula: wherein R1–R3 are as defined herein. The compounds of the invention are useful in the trea...
07/04/2006
6930076Nematicidal trifluorobutenyl imidazole thioether derivatives
The present invention relates to novel trifluorobutenyl imidazole thioether derivatives of the following formula (I) wherein R1 represents hydrogen or halogen, ...
08/16/2005
6916837Amidino derivatives and anticoagulants and thrombosis therapeutic agents containing them
Amidino derivatives represented by the following general formula (I): {where X is a group represented by R1SO2NR2— (wherein R1 represents optionally substituted C6-14 ...
07/12/2005
6815445Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
The present invention is directed to a compound of Formula I: wherein A, R1, and R2 are defined herein. The present invention is also directed to compositions comprising compounds of Formula I, me...
11/09/2004
6706887Process for the preparation of alkylimidazolidone (meth)acrylates
The invention relates to a process for the preparation of alkylimidazolidone (meth)acrylates, generally expressed as compound (I): that are prepared by reacting at least one (meth)acrylate of formula (II):
03/16/2004
6696456Beta disubstituted metalloprotease inhibitors
Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have a structure according to the following Formula (I): #...
02/24/2004
6586452C1 to C4 side chain modified nodulisporic acid analogs
The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents....
07/01/2003
6545157Dye-forming method, color developing compositions, photosensitive materials and color developing agent precursors
A dye-forming method comprising: reacting a dye-forming coupler and a color developing agent precursor represented by the following general formula (I): ##STR1## wherein A3 represents a group other than a hydrogen atom which leaves, accomp...
04/08/2003
6541635Method for producing angiotensin converting enzyme inhibitor
The present invention discloses a method for producing angiotensin converting enzyme inhibitor of the following formula (I) and pharmaceutically acceptable salts thereof, in which a compound of the following formula (II), ##STR1## wherein R and R
04/01/2003
6515138Transesterification process
An improved transesterification process is disclosed for forming certain (meth)acrylates by the transesterification of an alkyl (meth)acrylate with a hydroxyl alkyl imidazolidin-2-one using a transesterification catalyst in the presence of a polymerizatio...
02/04/2003
6479478Carbapenem compounds
It is provided carbapenem compounds represented by the following formula (I): ##STR1## wherein R is hydrogen atom, or substituted or unsubstituted lower alkyl group; and, n is an integer of 1 or 2, or a pharmaceutically acceptable salt thereof, and an antibact...
11/12/2002
6472529Retroviral protease inhibiting compounds
A compound of the formula: ##STR1## is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed....
10/29/2002
6472414Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure ##STR1## including pharmaceutically acceptable salts thereof or prodrug esters...
10/29/2002
6465650Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids
The invention provides a processes for the preparation of a compound of Formula I, or a salt thereof ##STR1## wherein PG is a urethane- or trityl-type protective group; X is NH, O, or S; Y is CH2, O, or NH; and B' is a base customary in nucleot...
10/15/2002
6362183Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
An aromatic sulfonyl alpha-hydroxy hydroxamic acid compound that, inter alia, inhibits matrix metalloprotease activity is disclosed, as is a treatment process that comprises administering a contemplated aromatic sulfonyl alpha-hydroxy hydroxamic acid comp...
03/26/2002
6335451Five-membered heterocycles having biphenylsulfonyl substitution, with sulfonylcyanamide side chain, compositions containing them, and methods of using them
Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them. Compounds of the formula I ##STR1## in which the symbols have the meanings indicated i...
01/01/2002
6228848Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
Aryl-substituted and aryl and (3-oxo-1-propenly)-substituted benzopyran, benzothiopyran, 1,2-dihydroquinoline, and 5,6-dihydronaphthalene derivatives have retinoid negative hormone and/or antagonist-like biological activities. The invented RAR antagonists...
05/08/2001
6191157Hetero-linked phenylglycinolamides
The hetero-linked phenylglycinolamides are prepared by reaction of the corresponding hetero-linked phenylacetic acids with appropriate phenylglycinols. The hetero-linked phenylglycinolamides are suitable as active compounds in medicaments....
02/20/2001
6179906Cyclic urea surfactants
This invention provides water-based compositions, particularly coating, ink, and agricultural compositions, manifesting reduced equilibrium and dynamic surface tension by the incorporation of a surface tension reducing amount of certain cyclic urea compou...
01/30/2001
6172057N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
Matrix metalloproteinases (MMPs) are a group of enzymes that have been implicated in the pathological destruction of connective tissue and basement membranes. These zinc containing endopeptidases consist of several subsets of enzymes including collagenase...
01/09/2001
6166220Ethylenically unsaturated imidazidolidinone monomers
Classes of urea functional compounds and compositions containing the same are disclosed which are particularly suitable for use as a wet adhesion promoters in coatings, especially in aqueous emulsion systems used to make latex paints. Compositions contain...
12/26/2000
6147097Imidazole derivatives as anti-HIV agents
An imidazole derivative represented by general formula (I) or a salt thereof, having the effect of specifically inhibiting the growth of HIV as a pathogenic virus and being reduced in toxicity. In said formula R1 represents hydrogen, C1
11/14/2000
6080870Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invent...
06/27/2000
6075143Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids
There are described N-ethylglycine derivatives of the formula I ##STR1## in which PG is a urethane-type or trityl-type amino protective group which is labile to weak acids, X is NH, O or S, Y is CH2, NH or O, and B' are bases customary in ...
06/13/2000
6071935Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
The present invention relates to compounds of the formula ##STR1## wherein R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of form...
06/06/2000
6057448Process for producing imidazole derivatives
The present invention provides a process for producing a compound of the formula (III): ##STR1## wherein R1 and R3 are independently hydrogen or an organic group; R2 is an organic group; and R4 is an option...
05/02/2000
60569652-mercapto-imidazole derivatives substituted in position 4 (or 5) as antioxidizing agents, method of preparation and applications in the pharmaceutical, cosmetic or food industries
The invention relates to 2-mercaptoimidazole derivatives substituted in the 4(or 5)-position. These 2-mercaptoimidazole derivatives are of the general formula (I) below: ##STR1## wherein: R1, R2, R5, R7 and R
05/02/2000
6054590Imidazolone anorectic agents: II. phenyl derivatives
A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of phenyl derivatives of imidazolone compounds of Formula I. ##STR1## As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expecte...
04/25/2000
6040328Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
The objects of the present invention are: novel organoselenium compounds: aromatic diselenides and selenosulphides; the use of said novel compounds as antioxidant agents; pharmaceutical compositions containing them; a method of preparation of said novel compounds. Said ...
03/21/2000
6018049Process for the preparation of carbamoylated imidazole derivatives
The present invention provides a process for the preparation of a compound of the formula (III): ##STR1## wherein R1 is an optionally substituted alkyl or an optionally substituted aryl; R2 is an optionally substituted alkyl: R
01/25/2000
6008371Process for the preparation of (meth)acrylic acid esters
A catalytic process for the preparation of (meth)acrylic acid esters of formula (I), in which R1 is H or CH3 and A and B are unbranched or branched alkylene groups with 2 to 5 C-atoms, by reaction of (meth)acrylic acid esters of formula (II), i...
12/28/1999
5977377Process for producing N-alkylimidazole
Disclosed is a process for producing an N-alkylimidazole which comprises reacting an imidazole with an N-alkylating agent in an organic solvent in the presence of alkali particles having a specific surface area of 0.6 M2 /g or larger....
11/02/1999
59525101,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity
The present invention concerns the compounds of formula ##STR1## the N-oxide forms, the pharmaceutically acceptable acid or base addition salts and the stereochemically isomeric forms thereof, wherein R1 and R2 each independentl...
09/14/1999
1            
 
Sign InRegister
Username  
Password   
forgot password?